Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 18/20 | 1.00 |
| ▸ | SULT1A1 | P50225 | 4/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Flutemetamol F 18 SCHEMBL30668500 | 1.00 | APP (1.00) | APPSULT1A1MAPT | |
| Flutemetamol SCHEMBL10032130 | 1.00 | APP (1.00) | APPSULT1A1MAPT | |
| Flutemetamol F 18 SCHEMBL29363499 | 1.00 | APP (1.00) | APPSULT1A1MAPT | |
| SCHEMBL5958763 | 0.87 | APP (0.77) | APPSULT1A1MAPT | |
| SCHEMBL14788828 | 0.86 | APP (0.75) | APPSULT1A1MAPT | |
| SCHEMBL15604181 | 0.86 | APP (0.75) | APPMAPT | |
| SCHEMBL13167852 | 0.85 | APP (0.73) | APPSULT1A1MAPT | |
| SCHEMBL2061295 | 0.85 | APP (1.00) | APPSULT1A1MAPT | |
| SCHEMBL12227066 | 0.85 | APP (1.00) | APPSULT1A1MAPT | |
| SCHEMBL13806265 | 0.84 | APP (0.73) | APPSULT1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12514937-B2 | Methods for detecting CCR2 receptors | WASHINGTON UNIVERSITY (US) | 2026-01-06 | — | — | US | claimed |
| EP-4330662-B1 | ANALYTICAL HPLC | GE HEALTHCARE LTD (GB) | 2025-09-03 | — | — | EP | claimed |
| US-20250229109-A1 | MONITORING TISSUE PERMEABILITY DURING ULTRASOUND PROCEDURES | INSIGHTEC LTD (IL) | 2025-07-17 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| WO-2025054524-A1 | METHOD FOR DIAGNOSING AMYLOID DISEASES | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2025-03-13 | — | — | WO | claimed |
| EP-4496618-A2 | MONITORING TISSUE PERMEABILITY DURING ULTRASOUND PROCEDURES | Insightec Ltd. (IL) | 2025-01-29 | — | — | EP | claimed |
| US-20240302338-A1 | ANALYTICAL HPLC | GE HEALTHCARE LTD (GB) | 2024-09-12 | — | — | US | claimed |
| US-11964020-B2 | Method for removing acetaldehyde | GE HEALTHCARE LIMITED (GB) | 2024-04-23 | — | — | US | claimed |
| EP-4330662-A1 | ANALYTICAL HPLC | GE Healthcare Limited (GB) | 2024-03-06 | — | — | EP | claimed |
| WO-2023180811-A2 | MONITORING TISSUE PERMEABILITY DURING ULTRASOUND PROCEDURES | INSIGHTEC LTD. (IL) | 2023-09-28 | — | — | WO | claimed |
| US-11756193-B2 | Method and apparatus for diagnosing Alzheimer's disease using PET-CT image | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION (KR) | 2023-09-12 | — | — | US | claimed |
| EP-4190242-A1 | METHOD FOR DIAGNOSING ALZHEIMER'S DISEASE USING PET-CE IMAGE AND APPARATUS THEREOF | Samsung Life Public Welfare Foundation (KR) | 2023-06-07 | — | — | EP | claimed |
| US-20230153991-A1 | METHOD AND APPARATUS FOR DIAGNOSING ALZHEIMER'S DISEASE USING PET-CT IMAGE | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION (KR) | 2023-05-18 | — | — | US | claimed |
| WO-2022229155-A1 | ANALYTICAL HPLC | GE HEALTHCARE LIMITED (GB) | 2022-11-03 | — | — | WO | claimed |
| US-20220305126-A1 | METHOD FOR REMOVING ACETALDEHYDE | GE HEALTHCARE LIMITED (GB) | 2022-09-29 | — | — | US | claimed |
| WO-2022030692-A1 | METHOD FOR DIAGNOSING ALZHEIMER'S DISEASE USING PET-CE IMAGE AND APPARATUS THEREOF | 사회복지법인 삼성생명공익재단 | 2022-02-10 | — | — | WO | claimed |
| EP-4744053-A1 | SYSTEMS AND METHODS FOR PREDICTING BRAIN TAU OR AMYLOID LEVELS | Eisai R&D Management Co., Ltd. (JP) | 2026-05-20 | — | — | EP | disclosed |
| EP-4743785-A1 | ANTIMICROBIAL PEPTIDES | Eisai R&D Management Co., Ltd. (JP) | 2026-05-20 | — | — | EP | disclosed |
| US-20080286202-A1 | Method of Diagnosing Prodromal Forms of Diseases Associated With Amyloid Deposition | UNIVERSITY OF PITTSBURGH (US) | 2008-11-20 | — | — | US | disclosed |
| US-20080219931-A1 | Amyloid Imaging as a Surrogate Marker for Efficacy of Anti-Amyloid Therapies | UNIVERSITY OF PITTSBURGH | 2008-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220305126-A1 | METHOD FOR REMOVING ACETALDEHYDE | ALDH2, ALDH1A1, ADH1A | APP 3605/4885SULT1A1 437/4885MAPT 2218/4885 |
| US-11964020-B2 | Method for removing acetaldehyde | ALDH2, ALDH1A1, ADH1A | APP 3605/4885SULT1A1 437/4885MAPT 2218/4885 |
| US-20080219931-A1 | Amyloid Imaging as a Surrogate Marker for Efficacy of Anti-Amyloid Therapies | TTR, APP, SAAL1 | APP 2/4885SULT1A1 2536/4885MAPT 14/4885 |
| US-20080286202-A1 | Method of Diagnosing Prodromal Forms of Diseases Associated With Amyloid Deposition | PSEN2, PSEN1, APP | APP 3/4885SULT1A1 4158/4885MAPT 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.